Do you have #HER2positive#BreastCancer? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: bit.ly/EA1211
Excited for 58 sites to be up and running with first accruals at multiple sites. On the way to answer this important imaging biomarker question. @RoisinMConnolly@SNM_MI@UCC#imagingbiomarker
Knowing your breast density is important because it can affect your risks for breast cancer and how you should be screened. Learn more in an expert-led webinar: wb.md/3ZQKz0R
Our own #RIMIRad, Dr. Dibble, was featured on the @SBC_org Podcast, where she talks about the latest advancements in breast imaging and the importance of early detection. Click here to listen to the entire podcast: ow.ly/kAyg50P8Z4M
📄 In Press @JACRJournal
"Given the current wide-open job market for radiologists...(&) the 2022 passage of paid family & medical leave policies by the ACR & AMA... practice leaders making hiring decisions may benefit from familiarity with the latter..."
jacr.org/article/S1546-1440(…
Can boosting familiarity with the Family Medical Leave Act ease the labor shortage many U.S. radiology practices face?
Associate Professor of Diagnostic Imaging @edibbleMD says it could.
Read more about this Brown-led study:
ow.ly/P1Rn50P4giq
Brilliant study of PET-FDG vs conventional staging for stage IIB-III early breast cancer by the Canadian colleagues. PET doubled the diagnoses of metastatic disease & prevented unnecessary intensive treatment in ~20% of the pts. Adequate staging is key! ascopubs.org/doi/abs/10.1200…
Thankful for widespread opposition to interference in the physician-patient relationship in the radiology community for reasons explained so well here by @katefd5. 24 state radiological societies (including RIRS!) have cosponsored #Resolution11. #Rads4Choice